BD Expanding Safety Needle Technology Platform With Saf-T-Med Buy
This article was originally published in The Gray Sheet
Executive SummaryBecton Dickinson plans to initiate marketing feedback studies of Saf-T-Med's Easy Safe retracting needle syringe within 12 months, the company says.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.